Our lab has recently demonstrated that normal hepatic eNOS activation is dramatically reduced in the obese OLETF rat during the transition from hepatic steatosis to NASH (Sheldon et al., 2014), implicating the loss of normal eNOS function in the advancement of liver disease. Here, NOS3 is linked to Hepatic steatosis.